
    
      Collection of data and retrospective analysis of patients with high risk prostate cancer
      treated with radiotherapy to pelvic lymph nodes.

      What influence has irradiation of pelvic lymph nodes on patients with high risk prostate
      cancer in terms of progression free survival and toxicity. How does this influence side
      effects with respect to gastrointestinal (proctitis, abdominal pain, diarrhea) and
      genitourinary (cystitis, urinary disorders) toxicities (CTCAE v4.03)
    
  